0% found this document useful (0 votes)
12K views168 pages

University of Utah Emails About Huntsman Cancer Institute

The University of Utah on Aug. 11, 2017, released a batch of emails The Salt Lake Tribune had requested through an open-records request for correspondence between University of Utah President David Pershing, former Health Sciences VP Vivian Lee, and Huntsman Cancer Institute CEO Mary Beckerle regarding funding negotiations and leadership of the institute. The Tribune has removed from this document 22 pages from the subscription-based Cancer Letter.
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF or read online on Scribd
0% found this document useful (0 votes)
12K views168 pages

University of Utah Emails About Huntsman Cancer Institute

The University of Utah on Aug. 11, 2017, released a batch of emails The Salt Lake Tribune had requested through an open-records request for correspondence between University of Utah President David Pershing, former Health Sciences VP Vivian Lee, and Huntsman Cancer Institute CEO Mary Beckerle regarding funding negotiations and leadership of the institute. The Tribune has removed from this document 22 pages from the subscription-based Cancer Letter.
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF or read online on Scribd
You are on page 1/ 168
From: voian Lee To: ‘David Pershing ‘Subject: ‘Monday’ HCF board mtg Date: ‘Saturday, Moreh 25, 2016 10:18:45 AM Hi Dave, Sony to bother you again on a weekend. Mary sent this to me for Monday's mig. [understand Jon is planning on attending and running the mi We are still working with our team to develop the business plan for the ‘new buildingemy main concer is that for all the millions we are pouring into HCI, we're not seeing that much return in terms of research productivity. So we're trying to set up those expectations. They got another $1.2m from the state this year (one time). And welve sent lover a record $ from the hospital revenues. I believe Susan and Tam Muir (their CFO) are ok with the $. They always want more. And right now we ‘want to keep making the case that we need them to be a part of capital investments, eg. In Farmington and Lehi, That future clinical success ‘depends on them being a pat ofthe health system and investing with us, Another sometimes point of fiction is in marketing, but right now my sense is that Sue Sheehan foves Dave Perry and they appreciate our central ‘marketing team is awesome compared to their internal group. (At some point Jon said he didn’t want any of his § going o support U of U/Health ‘Sciences marketingcand so this caution and extra discussion is because of that). Note we do have a writer for NYT magazine interested in including a Jot of material aboutus in that series of features on cancer. ‘A couple of other sticky points with him. He wants fo be in the top 50 of | cancer institutes. Mary will highlight the lack of Nursing magnet status. David E and | are moving forward with this (rate limiting factor was that ‘many of our nurses didn't have BA degrees, and so we've sent them back t0 ‘using school over the past 4 yearsSalmost done now). David ison it. Really what should be the focus is that we need more major grants from HClethat would be most helpful for bringing our reputation up. For the $ we've put in, we're not performing. Lastly, we are really gratefl that he has committed some more § to build ‘out the shelled part of the phase TV building. I'l get more details on that for you by Monday so you'll know exactly what to thank him f Let me know if you have other questions. ‘Thanks much, Vivian >We have an HCF Board meeting scheduled for Monday afternoon. Dave P. >will be there, along with Scott Anderson. Susan has indicated that focus will be on finance issues related to the Foundationdl may have it Joncat this point [only have >the agenda that I received from Susan this morning. Am attaching the >draft agenda in case you want to give Dave a preview. > Best. m >Message from Susan Sheehan: >Thanks Mary. We are focus more on the business of the foundation at this meeting than scientific information, We need to get some housekeeping done so forgive the fact that we are so focused on $ instead of science. Here isa draft agenda: Chairman, Jon M, Huntsman, J, is excused. Meeting will be presided >over and conducted by Chairman Emeritus, Jon M. Huntsman, Sr. 1. Weleome - Jon M, Huntsman, Sr, Chairman Emeritus >2. Approval of minutes of January 22, 2015 Board Meeting - Ron Mofiitt 23. Approval of Conflict of Interest Policy - Ron Moffitt 4, Report from CEO, Peter Huntsman (via telephone) >a, CYS Fundraising Results 5. Report from President & COO - Susan Sheehan >a. Funding for Phase 1V >b. Integrated Media Campaign >. Cancer Moon Shot Initiative >6. Financial Reports - Tom Muit >a. Proposed CY16 Budget >b, Foundation Balance Sheet >1. Report from CEO & Director, Huntsman Cancer Institute - Mary Beckerle, >PhD >a, Review of HCI Research Budget >b. Review of HICH Revenue & Revenue Sharing (I have @ copy ofthe revenue sharing schedule from David Browy inthe packet) >e, Comprehensive Cancer Center Designation >8. Other Business >Cheers, Mary From: David. Pershing To: an Lge ‘Subject: Re: Senda HOF board meg Date: Sunday, March 27, 2016 6:13:37 PM Vivian, ‘Thanks so much for this heads up. It will definitely help me be much ‘more prepared for the meeting as we don't get agendas in advance. Dave (On 3/26/16, 10:11 AM, "Vivian Lee” wrote: >Hi Dave, Sorry to bother you again on a weekend, Mary sent this to me for Monday's mtg. I understand Jon is planning on attending and running the cg. >We are still working with our team to develop the business plan for the ‘new buildingemy main concem is that forall the millions we are pouring into HCI, we're not seeing that much return in terms of research productivity. So weir trying to set up those expectations. They got another $1.2m ftom the state this year (one time). And welve sent over a record $ from the hospital revenues, I believe Susan and Tom Muir (their CFO) are ok with the $, They always want more. Aad right now we ‘>want to keep making the case that we need them to be a pat of capital investments, e.g In Farmington und [chi That future clinical success depends on them being a pat of the health system and investing with us Another sometimes point of fretion is in marketing, but right now my >sense is that Sue Shechan loves Dave Perry and they appreciate our central marketing team is awesome compared to their internal group. (At some point >Jon said he didn't want any of his $ going to support U of Uealth Sciences marketing.and so this caution and extra discussion is because of >that). Note we do have a writer for NYT magazine interested in including a >lot of material about us in that series of features on cancer. >A couple of other sticky points with him. He wants to bein the top 50 of | cancer institutes. Mary will highlight the lack of Nursing magnet status, David F and { are moving forward with this (rat Timiting factor was that ‘many of our nurses didn’t have BA degrees, and so we've sent them back to nursing school over the past 4 yearsSalmast done now). David is n it Really what should be the focus is that we need more major grant from >#Clethat would be mos helpful for bringing our reputation up. For the $ we've put in, we're not performing. >Lastly, we are really grateful that he has committed some more $ to build >out the shelled part ofthe phase IV building. Pil get more details on >that for you by Menday’ so you'll know exactly what t thank him for Let me know if you have other questions. >Thanks much, >Vivian >>We have an HCF Board meeting scheduled for Monday afternoon. Dave P. >>will be there, along with Scott Anderson, Susan has indicated that >efocus will be on finance issues related to the Foundations | may have >>more insight on Monday after { meet with Joncat this point {only have >>the agenda that I received from Susan this morning. Am attaching the >>draft agenda in case you want to give Dave a preview. >>Best. m >Message from Susan Sheehan >>Thanks Mary. We are focus more on the business ofthe foundation at this >>meeting than scientific information. We need to get some housekeeping >>done so forgive the fact that we are so focused on $ instead of science. >>Here is adraft agenda: >>Chalmman, Jon M. Huntsman, Jr, is excused. Meeting will be presided mover and conducted by Chairman Emeritus, Jon M. Huntsman, Sr. >>. Weleome - Jon M. Huntsman, Se, Chairman Fmeritus >>2, Approval of minutes of January 22, 2015 Board Meeting - Ron Moffitt, >>3. Approval of Conflict of Interest Poliey - Ron Moffitt >>4, Report from CEO, Peter Huntsman (via telephone) >>a. CYS Fundraising Results >>S, Report from President & COO - Susan Sheehan >>a. Funding for Phase IV >>b, Integrated Media Campaign >>e, Caner Moon Shot Initiative >>6. Financial Reports - Tom Mui >>a, Proposed CY16 Budget >>b, Foundation Balance Sheet >>7. Report from CEO & Director, Huntsman Cancer Insitute - Mary Bockerle, PhD >>a, Review of HCI Research Budget >>b, Review of HCH Revenue & Revenue Sharing (I have a copy of the revenue ‘>>sharing schedule from David Browdy in the packet) >>, Comprehensive Cancer Center Designation >>8, Other Business >>Cheers, Mary From: sianes Te: vid Pcsting Subject: HOF Date: Suny, March 27, 2016 6:35:02 AM Tho rest ofthe ston ‘Thanks! (On 3/26/16, 4:28 PM, "Mary Beckerlo" wrote: >The cost to build out ofthe filth floor is approximately $4.5Million. >The fifth floorspace will be key to clinical research excellence and expansion. HCT is covering half the eost from cash and Jon agreed that >the Foundation would cover the other half, M From: vivian Lee to: ‘David wl Pershing Subject: A Draft Statement ate: Sunday, May 01,2016 9:49:35 Hi Dave, When Kathy and | talked this afternoon, she shared with me the thought that maybe it would be a good time to consider a very positive and open communication from you to the campus about how we are thinking—why we're not pulling back the degree, and why as universities we must engage in open dialogues and to learn and to make progress together. kathy brought in some of the other members of our team to draft this statement—I've not edited it. Sending it along for your reflection. I think they could be onto a good idea. Have a good night. See you in the morning (By the way, I had a productive conversation with Susan last week, followed by another reasonably productive conversation with Mary which revealed a few differences of opinion between her and Susan...) Thanks, Vivian From: ivan Lee To: avid, Pershing ‘Subject: Salaries fr crect reports to review wi the President PH Conde Date: “Twesdoy, June 07,2016 10:00:42 PH ‘Attachments: IFRS DDRE.4836.8506-24S4SBBFAEBOL26}. ong YW Incense Reconmendatens = Vian ee nal to Ped xis Dear Dave, Hope your travels are going well. Given we won't see each other for another couple weeks, | thought I'd share this with you electronically for your review and approval, if that seems ok Most of the increases are in the 2-4%, | would like to discuss Mary's situation—so for now we've put in the cost of ving increase as a holder, ‘There are a few more significant increases which all have to do with increases in scope of responsibilty For Dave Browdy, as CFO he’s now also taken on the leadership of the entire $21 project. For Grant Lasson, as Chief Strategy Officer he's now also taken on the responsibilities for the Regence strategy. Catalina and Steve Petersen have taken on expanded financial responsibilities. You'll see the notes off to the right side of the spreadsheet to explain. Please let me know if you have questions or concerns. Thanks so much, Vivian From: DAVID BROWDY Date: Thursday, June 2, 2016 at 5:26 AM To: Vivian Lee ‘Subject: Salaries for direct reports to review with the President PHI Confidential Hivivian, Attached isthe spreadsheet of proposed increases for your direct reports to review with President Pershing, I've taken a stab at justifications in the far right column. Please let me know if you need additional info from me on this. Thanks, David David H. Browdy Associate Vice President for Finance and Chief Financial Officer for the Health Sciences University of Utah 801.587.9566 david.browdy@hscutahedu Executive Assistant: Heather Hatch 801.585.3748 [email protected] Gis: 35 From: Dai Pashing To: viva Lee Subject: Re: Salaries for trek reports to review wth the Print PHE Conder Date: Weeinestay, une 08, 2016 3:04:18 PM Attachments: (SES8-DDSE-46-B5D6-4S45ROF 1En9(261.0n0 Dear Vivian, {have finally had a chance to study these recommendations this evening and I believe that | can support your plan. Yes, we can surely talk about Mary's increase after | get back | like what you are doing for those who are taking on major additional responsibilities. As you know, these are big numbers in main campus terms, but that s just the way itis, We clearly do not want to loose any of these key people. We also need to talk about your own bonus this year the next time we are together. Best, Dave From: Vivian Lee Date: Wednesday, June 8, 2016 at 5:00 AM To: UCCS Subject: Salaries for direct reports to review with the President PHI Confidential Dear Dave, Hope your travels are going well. Given we won't see each other for another couple weeks, I thought share this with you electronically for your review and approval, if that seems ok. Most of the increases are in the 2-494, | would like to discuss Marys situations for now we've putin the costo living increase asa holder. ‘There are afew more significant increases which all hve to do with increases in scope of responsibilty. For Dave Browdiy, 2s CFO he's naw also taken on the leadership ofthe entire 521 project. For Grant Lasson, as Chief Strategy Officer he’s now also taken on the responsibilities for the Regence strategy. Catalina and Steve Petersen have taken on expanded financial responsibilities. You'll see the notes off to the right side of the spreadsheet to explain, Please let me know if you have questions or concerns. ‘Thanks so much, Vivian From: DAVID BROWDY Date: Thursday, June 2, 2016 at 5:26 AM To: Vivian Lee Subject: Salaries for direct reports to review with the President PHI Confidential Hi Vivian, Attached is the spreadsheet of proposed increases for your direct reports to review with President Pershing. 've taken a stab at justifications in the far right column, Please let me know if you need additional info from me on this. Thanks, David David H. Browdy Associate Vice President for Finance and Chief Financial Officer for the Health Sciences University of Utah 801.587.9566 david browdy@hsc utahedu Executive Assistant: Heather Hatch 801.585.3748 heatherchatch@hscurahedu From: atheen (Katt) Cooney Tor ‘vin. Lee cc: Daniale Samo; Josehine Rudd Subject: Re: Thankyou an another introduction Pate: “Thursday, June 23, 2016 2:44:25 PH {am here on Monday PM. Thx. Sent from my iPhone > On Jun 23, 2016, ut 2:30 PM, Vivian Lee wrote: > Kathy are you around Monday afternoon? I'm in Vegas and coming back at 437 pm. don’t know if $ pm would be too late for Mr, Huntsman, Before asking team to check, thought I'd check with you. Thanks. > On 6/23/16, 1:16 PM, "Pam Bailey" wrote! > Dr. Lee, > Mr. Huntsman would be honored to meet Dr. Cooney. He will be in town next > woek and could make him available on the following dates: Monday, June 27, after 1:00 ‘Tuesday, June 28, after 12:00 Wednesday, June 29, after 2:00 ‘Thursday, une 30, ater 2:00 > Please let me know if any of these days could work for you and Dr. Cooney, > Thank you, All the best, > Pam > Pam Bailey > Assistant to Executive Chairman Jon M. Huntsman > Huntsman Corporation $00 Huntsman Way > Salt Lake City, UT 84108 > (801) 584-5942 > (B01) 584-5701 (fa) >From: Vivian Lee >To: Pam Bailey , > Ce: "Kathleen (Kathy) Cooney” , > Josephine Rudd >Date: 06/12/2016 04:51 PM > Subject: Thank you and another introduction > Dear Pam, > Could you please relay this message to Jon, and ifhe’s amenable, could you > also work with us to find atime for me to bring Dr. Kathy Cooney for an > introduction? > Thanks so much! > Vivian > Dear Jon, > Thank you so very much for taking time out of your very busy schedule to > visit with me and John Baker. Coming out ofa long eareer in fund-raising > for cancer at USC, you can imagine that your reputation loom very large in > his mind, and he was jut so thrilled to be uble to come and meet you. > Walking away with not one, but two autographed books, well [think he was > on cloud nine. > Ie was also a real treat for both of us to connect with Paul. 'm always so > impressed with how thoughtful and strategic Pal is, in a very understated > way. We are truly so fortunate to have him at the helm of our Salt Lake > Tribune. The importance ofthat media outlet to our city and its > attractiveness to people across the country cannot be underestimated, in my > We will continue to work closely with Susan to try to improve our > fund-raising for eancer, especially in the “grateful” patient space. I have > allot of confidence in Joh and [know he will work very hard to make a > difference, in partnership with Susan. > At the risk of over-imposing ourselves on you, I did want to follow-up on > our discussion about the possiblity of introducing you to Kathy Cooney. As > you know, Dr. Cooney is our new Department Chair of Internal Med > hailing from University of Michigan, where she was Chief of > Hematology/Oncology and Deputy Director of the Comprehensive Cancer > Institute there. She has had a distinguished career on prostate cancer > research, In the fall as she was accepting this position, she submitted 4 > federal grant proposals, and was delighted (and slightly overwhelmed) to > find herself (and now the University of Utah) receiving thre of them! > Here's a link to our release about her arrival > hutphealtheare.uiah ed/publicalfairvnews/2015/10/11-4-1SCooneyAnnounce.php > She would be so thrilled to meet you. > Tknow you've headed to Europe. I hope you're having a great trip. Perhaps > whem i's convenient, we ean head over fora brief introduction?! > Thanks so much again for your kindness, generosity, and indefatigable > spirit. Take care and see you soon, > Vivian From: ivan bee Tor David. Pershing Subject: Re: Cartan Dater “Thursday, Septeber 15,2016 5:09:19 PM Good, ‘Almost back—meeting Mary 8 for dinner, Hope you had a good rest of the meeting. And I really hope we end up #1. Fingers crossed, Thanks so much, Vivian From: eam Bae Ter nner sing Vian Lee; Mary Bache Subject: ete oO ard Bena fom Me. Huntsman Datar Thurstay, Ober 20,2016 3:59:04 Ft Attachments: ,61020.51927928.ct Please receive via attachment a copy ofa eter sent to Dr. Edward Benz from Mr. Huntsman, Pleas let me know ifyou have any questions. Best wishes, Pam Pum Bailey Huntsman Corporation 300 Hunan Way Salt Lake City, UT 84108 (801) 584-5942 (801) 584-5701 (fax) (Gee atached file: 20161020154927928 pat HUNTSMAN CRICER FOUNDATION October 20, 2016 ‘Bdward J. Benz, Jt, MD President and CEO Emeritus Dana-Farber Cancer Institute 450 Brookline Avenue, DA 1644 Boston, MA 02215-5450 Dear Bd: Your letter of October 17 was received and is hereby gratefully acknowledged, As chairman of Huntsman Cancer [nstitute’s Extemal Advisory Board (EAB), while simultaneously serving as President and CEO Emeritus of Dana-Farber Cancer Institute, it was a great honor and a rare privilege to receive such an outstanding report on behalf of the board, Your remarks regarding the progress of HCI this past year were gratefully appreciated. You and your board comprising the EAB represent the brightest and most knowledgeable experts in the cancer field. Our senior staff, researchers and every individual involved with HCl has worked energetically and enthusiastically to be recognized as a Comprehensive Cancer Center by NCI. Your comments regarding our leadersbip team and our strategy going focward were well received and, from my observation, well deserved. We continually work on HCI’s major role in defining, the direction and strategy for the development of our clinical cancer programs. Twill always remain grateful for the personal time you spent with me during your last visit to Salt Lake City, We all hold you and the other members of the EAB in such high regard ~ but I pattcularly express my gratitude to you as chairman and for the personal interest you have taten in helping us to remain focused on our goals and priorities. We could have no greater cheerleader than Edward J. Benz, Jt. My heartfelt appreciation and deepest gratitude, With respect, Mica cc: President David W. Pershing Dr. Vivian S, Lee Mary Beckerle, PRD | | i { { DANA-FARBER en Pk October 17, 2016 Pmt sees Mr. Jon M. Huntsman [per to oe a Huntsman Corporation eatrrtine enn,OA 14h 500 Huntsman Way fen at Salt Lake City, UT 84108 ‘sar ors hk Dear Me, Huntsman: HCI’s Extemal Advisory Board (EAB) enjoyed a very productive and informative meeting: with the HCI leadership, faculty, and staff, earlier this year. ‘The major development that had ‘ocurred between this meeting and the prior one was the highly successful review of the CCSG. renewal, with an exceptional priotity score of 19, and the awarding of NCI designation as a Comprehensive Cancer Center. The EAB regards this as an extraordinary accomplishment, culminating years of programmatic and administrative development of the HCI under the truly exceptional leadership of Dr. Mary Beckerle. Given that our meeting was occurring just after the successful renewal activity, we and the ICE feadership deemed that the best use of this meeting would be to reflect on the broader, longer term future of the HCI, rather than on the usual need to focus on the development of a proper positioning for renewal of the CSG. In keeping with this, Dr. Beckcrle opened the session with an overview of the FICI’s progress to date and the outcome of a number of longer term strategic visioning and planning sessions that she had led, both with her seniot management team and the entire faculty. What followed were a series of discussions about broad areas of particular interest and/or concem for the development of the Center's future, Based on all of these conversations, the BAB feels that HCI is making extraordinarily good progress, Dr. Beckerle’s leadership is superb, and she has progressively strengthened and broadened an effective senior leadership team that now covers the major components of an NCL designated comprehensive cancer center, We teel that the H{CI has done a remarkable job of strengthening its key elements, and has successfully engaged in the difticult process of integrating all of those elements in a manner that will maximize their synergy. A key element that has contributed to HCI's success is the Cancer Center's major role in defining the direction and strategy for development of the clinical cancer programs, This, for example, led to the pioneering integration of early phase clinical trials within the space for standard-of-care infusion, The EAB is fully supportive of HICI’s direction under the current leadership. The EAB remains extremely impressed with the broadening and strengthening of excellence in all areas of a comprehensive cancer center. In summary, the EAB is extraordinarily pleased with the progress of the HCL, with its outstanding leadership, with its responsiveness to our previous observations and suggestions, and with the clear leading role that Dr. Beckerle and other faculty are assuming Basses ee ‘on the national scene. Your support as the Founder of FICI has been pivotal in shaping INCI's exceptional trajectory and, on behalf of all cancer patients and their families, we salute you for your commitment to this important cause. Sincerely, Edward J, Benz, Jr, MD G From: David Pershing Te vin Lee Subject: Re: untae | Date: “Tuesday, November 08,2016 10:41:10 AM Interesting. While I was away at the Pac-12 meeting, Pam called and set up an appointment for PETER to meet with me this morning while he was up here from Houston. However, late yesterday they cancelled that because of business complications on his side and it has not been rescheduled. I have not hear anything from Paul but will let you know if! do. Please do the same. Hopefully he will contact you. Obviously we need to hang together on this. Dave From: Vivian Lee Date: Tuesday, November 8, 2016 at 11:37 AM To: David Pershing Subject: FW: Huntsman FYI with what's happening. From: Danielle Sample Date: Monday, November 7, 2016 at 11.03 AM To: u0777981 Subject: Huntsman Just talked with Pam. She said Jon is feeling better, but Jon told Pam that Paul was going to be calling you soon. | asked her if we could please schedule a specific time and she said she thinks we should just wait for Paul to reach out right now. | didn’t push back after that... let me know if | should follow up in a different way. avid W. Pershing Vion Lee Subject: Re! Jen ater Friday, November 1 2016 2:13:15 Pt Vivian, ‘This seems very good to me. | suspect that | will see him at the game tomorrow and will do my best to support you. Dave From: Vivian Lee Date: Friday, November 18, 2016 at 1:52 PM To: David Pershing Subject: Jon Iwas thinking of sending this email to Jon. If you think it’s going to make him mad, I won't. I just thought since won’t see him at the game tmrw, I wanted to fu with him about what's happening —this is remarkable news in my vuew, and by now Susan would have updated him ‘on some of the clinical strategic issues (insurance) so he would understand more what we're up against. What do you think? Dear Jon, ‘You have very much been in our thoughts, and I hope you're feeling wel We had our Huntsman Executive meeting yesterday and celebrated the great success of Huntsman Cancer Hospital this past year financially, and the continued growth of our regional network partnerships and new research advances. We approved the transfer of over $32M from the hospital margin (50%) to the Institute, as per our MOU. That is a remarkable achievement and level of support. I'm working closely with Mary to ensure that our research investments translate into high impact science that will improve the lives of our patients and really transform the cancer landscape—and which will gamer the national recognition I believe we deserve. We also discussed some of the challenges ahead in the clinical arena, and the very valuable ‘work our clinical strategy working group has been doing to plan for the future. That working group is cochaired by John Sweetenham (HCI clinical director), Kathy Cooney (whom you. met) and Sam Finlayson (Chair of Surgery), with Mary as a member, and supported by our strategy team for the health sciences led by a very capable person named Grant Lasson. If you are interested, we'd be happy to share with you and/or Peter or Paul the issues we're tackling. I'm sure we'd benefit enormously from your insights. Lastly, I should thank you for the use of the Huntsman Cancer Institute as the meeting place for our annual Rhodes scholarship selection committee. Tomorrow morning and afternoon, we will be convening our selection meeting in HCI, bringing 15 of some of the brightest 20- somethings for this scholarship competition, It couldn’t be in a more inspiring and beautiful environment, (Unfortunately it does mean we'll miss the Ute game). President Pershing has mentioned that there will be some communications with Peter and that ‘you have expressed concems about our MOU. I hope you believe that we are ever working, with the longterm interests of HCI at heart. The future success of the U’s Health Sciences is predicated on the success of HCI, and it is in cancer that we have the most urgent call for cures and compassionate care. If there is anything I can do to be helpful, please do let me know. ‘Thank you Jon for all that you have done and continue to do to make this place so special and great. Best wishes, Vivian viva Les Pama esage for Jon-thanks Pam Friday, November 18, 2015 2:15:27 PM Dear Jon, You have very much been in our thoughts, and I hope you're feeling well ‘We had our Huntsman Executive mesting yesterday and celebrated the great success of Huntsman Cancer Hospital this past year financially, andthe continued growth of our regional network. partnerships and new rescarch advances. We approved the transfer of over $32M from the hospital mangin (50%) to the Institue, as per aur MOU, ‘That is a remarkable achievement and level of suppor, and certainly is ming with the new building opening soon. {'m working closely with Mary to ensure that our research investments translate into high impact science that will Improve the lives of our patients and relly transform the cancer landscape—and which will gamer the national recognition I believe we deserve. We also discussed some ofthe challenges ahead inthe linia arena and the very valuable work our incl strategy working group has been ding to pln forthe fare. That working group is cohaired by John Swetenham (HCI cinical restr), Kathy Cooney (whom you met) and Sam Finlayson (Chai of Surgery), wth Mery a8 3 ‘member, and supported by our statey tam forthe health sciences le by avery capable person named Grant Lasson. IF you are interested, we'd he happy to share with you and/or Peter r Paul the issues we're tackling mn sure we'd benefit enormously from your insights Lastly, 1 should thank you forthe use ofthe Huntsman Cancer Institute as the meeting place for ur annual Rhodes scholarship selection committee. Tomorrow morning and aftemoon, we will be convening our selection meeting in HCI, bringing 15 of some of the brightest 20-somethings for this scholarship competition. It couldn't be in a more inspiring and beautiful environment. (Unfortunately it does mean we'll miss the Ute game). President Pershing has mentioned that you have expressed concers about our MOU and that there sill be some ‘communications with Peter. Tope you believe that we are ever working with the longterm interests of HCI at heat. The future success ofthe U's Health Seiences is predicated on the success of HCl, an hhave the most urgent call for cures and compassionate care. If there is anything t can do to be helpful, please do let me know. ‘Thank you Jon forall that you have done and continue todo to make this place so special and great. Best wishes, Vivian From: Davids Petsioa To: ‘idan Lee Subject: Het Datet Monday, Noverber 28, 2016 1:25:41 Hi Vivian, Just wanted to let you know that | now have a breakfast meeting with Peter Huntsman next Tuesday morning. Hopefully we can talk more about this during our meeting this Wednesday, both in terms of strategy and details. This is going to be tricky, but its important that we get off on the right foot with Peter. Dave From: Subject ‘Attachments: Mivianes Dav W,Pesshina Prep foe Peter ‘Thursday, December 01, 2016 12:08:04 PM Hi Dave, ‘Thanks so much for taking on this project! Six documents attached: Talking points 12_16 doc, which is the document you have already summarizing as much as T could think of HCH debt service payments since inception: your own electronic version of the overall HCH/HCI investments made to date that we reviewed yesterday ‘Summary of data HCI and Basic Sci.xls: The raw data are here for the graphs, and I've made 3 new worksheets in the excel file, one for each of the charts that are in the Talking points, and added some notes on annual growth (CAGR) and return on investment (ROD) as we discussed. CBO Report and Summary of CBO Partuers Phase I Report (2 files). [typed out a 1 page summary, with a bit more background to be maybe slightly more understandable tothe lay person, thought the summary could be added to the front of the Tam happy to have our office print these out for you, since you're traveling. Let us know what would be the most helpful Thanks so much Dave, Vivian “ (yovo %9'e) S1UeI9 HIN oKouneN/uQUInH/weY>OIg ‘nu Su] o1gosnaN /usQuINH /ws4>01g = (49¥2%'€)(a1840) sueID HIN-DH= = 498+ Hoddns n7 uewsyun} me STOzAd —STOZA_—«WTOZAY_-«=«ETOZAY_-«—««TOZAL_ «= TOZAA. «—«OTOZAY.«—««GOOZAY. «BOOTY. ««LOOZAY os 000'000'ss sak OT 48A0 104 %O6- YDVI %'E ‘SHIN IDH 000'000'0T$ 000'000'sts 000'000'0z$ MOV %9°E :SHIN 195 DISeg 49410 ; 000'00's7$ 00'000'0$ 00 '000's es 000'000'os parelosd WPS LTOZAS 000'000'srs WA QTAS-ZOAd Sulpuny ues HIN SA Sidaq aaualas a1Seg |OOYDS PaW JAYIO SA [DH O} YJeasay UI JUBWYSAAY] |eUONNYYSU] |eNUUY Talking points for Dave Pershing on HCI 12/16 1. HCI/HCH financials History of debt is noted in “HCH debt service payments” and "201611Huntsman Bond Commitments” # Phase | part 1 ($23.2M + interest) completely paid off, from $1.1M in federal loan (Forgiven) plus probably Health Sciences share of tobacco funds (split with HC1}; $12M support from HCl was “paid back” subsequently. ‘© Phase | part 2 (511M + $5M interest)) paid by Health Sciences share of tobacco funds. $4.8M + 0.4M interest remaining (to be paid by tobacco funds, see "201611 Huntsman Bond Commitments” © Phase II ($101.5M + accumulating interest) mostly paid by $89M federal loan (forgiven) plus Health Sciences share of tobacco funds, $2M left to be paid by tobacco funds Phase ill ($101.6M + $17M + accumulating interest) is ongoing 26M paid so far from HCH revenue, $127M to go which will be paid from HCH revenue (and when Phases | and Il are complete, also some tobacco funds, assuming they continue) * To be paid off by 2030 ($11M per year at the end) * Summary: HCI/HCH paid by $100M federal loan forgiven plus ongoing U of U Health Sciences share of tobacco funds (HCI receives half, UUHS receives half) and HCH margins ($150M) 2. HCI performance ‘+ Achieved comprehensive status from NIH with “exceptional” ratings, including exceptional evaluation of director and of the level of institutional support. ‘© Nationally there are 69 NCI designated Cancer Centers, and 45 of those are “Comprehensive” Cancer Centers. Huntsman achieved Comprehensive status last year ‘© 2015 First ranking within top 50 of US News and World Report Cancer Hospitals Taking together institutional support to the HCI from the MOU ($4 in FY08 to $22M in FY16 and $32M in FY17, from 50% of HCH margin), return of indirect funds, tobacco funds, cigarette tax, and HCF gifts (S6-10M per year), average overall support to HC! has increased from $6.6M in FY 07 to $37.5M in FY16 and expected to exceed $47.5M in FY17). © Cumulatively HCI has received over $223M in the past 10 years from Institutional support and HCF funding for operations (not including Capital, which is estimated to exceed $150M for phase Ill alone) ‘© With this investment, HCI NIH grants have increased from $10.7M (FY07) to $14.8M (FY16) for the primary HCI faculty for an average CAGR of 3.7% (-90.4% ROI), and from $40.5M (FY07) to $41M (FY16) for all primary and affiliated HCI faculty taken together (0.1% CAGR, -80.7% RO!) * In contrast, the U has invested in the three other basic science departments in the medical school (Biochemistry, Human Genetics (including Mario Capecchi) and Neurobiology) at totally of $42.4M during that same decade, and seen an overall increase from $15.8M to $21.7M in NIH funding (3.6%CAGR, 308% RO!) Annual & Cumulative Institutional Inv+HCF Support for HCI vs Other Med School Basic Science Depts (Biochem/Hum Gen/Neurobio) FY07-FY16 250,000,000 200,000,000 150,000,000 100,000,000 $50,000,000 so ro Fr2007F¥2008FY2009FY20I0 FY2OI FYP0I2 FOI FYZ018 F201. PIONS. —_sttuntsman UU Support +H1CF Huntsman institutional nv - Cuma = eBiochem/MumGen/Neurobio Instioy —_ mmiochem/HumGen/Newrobi Inst Inv Cum Annual Institutional Investment in Research to HCI vs Other Med School Basic Science Depts vs NIH Grant Funding FYO7-FY16 $50,000,000 $40,000,000 $30,000,000 $20,000,900 $10,000,000 so 2007 72008 FY2009 FY2O10 YAOI —~FY2OI2-FY7O13 Fr2OLA FYIOIS F206 Huntsman UU Support + HEF SHIN Grants (Org10) (3.7% CAGR —tiochem/HumGen/Neurobio ns = *Biochem/HumGen/Neurobio MH Grants (3.6% CAGR) Annual Institutional Investment in Research to HCI vs Other Med School Basic Science Depts vs NIH Grant Funding FYO7-FY16 (Incl $60,000,000 $50,000,000 $0,000,000 530,000,000 so ALL HC! & Affiliated Faculty NIH grants) ay ¢ ~ 2s « Fr2007FY2008 FY2009 FYZOIO. FYROM. FIDL FIDL FOIA FVII FYDOI6 Huntsman UU Support «HEF HCI ith atfiate Faculty) NIH grants (0.1% CAGR) —tinchemm/ttumGen/Neurobio Ins Inv iochem/MurnGen/Neurobio- NIM Grants (2.5% CAGR) © CBO consultants performed an analysis of HCI and primarily criticized them for inefficient use of resources, higher than expected compensation, lower than expected salary coverage on grants, very high clinical trials office costs, Summary of findin ° ° Over 20 percent of faculty working in HCI space have no extramural funding Faculty in HCI space covered only 24 percent of their salary on grants in FY15 57 percent of the faculty who receive salary support through HCI managed grants or revenues are above the median for their salary rank, department, and degree Net F&A recoveries on the HCI grant portfolio lag peers by 15% HCI only counted 16 percent of its building as research space in the calculation provided to CBO HCl researchers are charged such a small amount toward operation of core facilities that the core facility funding model seems unlikely to be self- sustaining, with very little of the core personnel supported on funded research grants. (CBO notes that the lack of support from funded grants will be interpreted as a weakness in future CCSG applications). ‘There is “very heavy subsidization of the Clinical Trials Office,” where HCI spends $12.2 million for the 511 patients who participate in research — (nearly $24,000 per research participant) 3. Clinical competitive landscape ‘* Intermountain is making an aggressive play to drive more business to IHC via their health plan (reducing “leakage”) * They have requested de-branding “Huntsman” name from their clinical care facilities ‘Select Health no longer offers the Select Care on individual exchange, small group, CHIP and FEHP, and expect that only 20,000 members will be left in Select care by early 2017 (down from 80,000 in 2014 and 130,000 in 2009, when the original agreement was executed) © Significant tightening of payments to pediatric physicians for the pediatric sb- specialty care, effective 11/16 (1% increase) + Onthe adult side, Select is trying negotiate a significantly more aggressive contract and restricting cancer care to HCI only (not South Jordan or Farmington) ‘We have a clinical cancer strategy working group, benefitting from Kathy Cooney's leadership (new Chair of Medicine/Oncologist and former Deputy Cancer Center chief at University of Michigan) together with John Sweetenham (Clinical Chief at HCI) and Sam Finlayson (Chair of Surgery) 4, Philanthropy ‘* The relationship between HCF (Susan Sheehan) and UU development has been contentious in the past, and seems to be improving, ‘Susan argues that any donor who has anything to do with cancer is her donor. ‘© Our physicians (who are typically the individuals the donors feel the most loyalty to) have grown averse to any interactions with HCF and HCI, and so we believe we are not really capturing most of the grateful patient population. With HCF, they get entangled in disputes with Susan over relationship management, and with HCI they feel that they have little say in the direction of the gift (HCF gave the money to HCI and Mary decided where to put the funds). Last year we began to implement a grateful patient initiative, after studying several other best practices (especially UCSF). This seems to be working very well. If patients indicate that they are interested in giving to Cancer, we inform Susan and have her team connect with the patient. If they are interested in both cancer and another area, we try to manage both those expectations. It's highly likely Susan is unhappy about something, although I’m not aware of any ongoing disputes. (Last case was a brain surgery patient of Bill Couldwell’s who wanted to donated an endowed chair to Neurosurgery which Susan tried to divert to HCI unsuccessfully) 5. Marketing '* Our marketing team has been trying to help HCI. They had a v weak web person and so Dave Perry has offered services from his team to support HCl. * I believe the relationship is reasonably positive. Note that Mary promoted her admin assistant to be the new head of marketing for HCI last year. Summary of CBO Partners Phase | Report August 29. 2016 CBO Partners is a consulting firm with expertise in academic medicine, who have been engaged by the University of Utah for the past 12 months to provide first a baseline assessment of the HCI Sources and Uses of Funds, with the intention of using these baseline data to perform a comparison with other Cancer Institutes and finally to model a proposed Strategic Plan for HC! to anticipate the funding needs for the long term success of HCl and expected outcomes. On the positive side, CBO notes: © Grants and contracts revenue grew by 14 percent from FY14 to FY15. ‘* HCI has enjoyed positive margins for at least eight years, creating significant reserves. CBO notes the following concerns, including corrections provided by Scott Lloyd from HCI last week: © Over 20 percent of faculty working in HCI space have no extramural funding. All research scientists are expected to obtain funding from sources like the NIH, foundations and industry. New junior faculty may take 2 ~ 3 years to secure their first funding. All others should have enough funding to cover the costs of their research and a significant portion of their salaries supported externally ‘+ Faculty in HCl space covered only 24 percent of their salary on grants in FY15. All basic science faculty outside of HCI in departments like Biochemistry, Human Genetics, and Neurobiology are expected to secure at least half of their salary on grants. This is particularly notable because HC! faculty have added benefits that other faculty do not, including approximately $80,000 - $120,000 in supplemental funding for their research programs each year, just by virtue of being an HCI researcher. «57 percent of the faculty who receive salary support through HCI managed grants or revenues are above the median for their salary rank, department, and degree ‘+ Net F&A recoveries on the HCI grant portfolio lag peers by 15%. Facilities & Administrative costs are provided by NIH and other federal research grants. This lag reflects the overall lower than expected federal research funding '* HCl only counted 16 percent of its building as research space in the calculation provided to CBO of the measure of dollar density, measurements of research productivity per square foot of space HCI researchers are charged such a small amount toward operation of core facilities that the core facility funding model seems unlikely to be self-sustaining, with very little of the core personnel supported on funded research grants. (CBO notes that the lack of support from funded grants will be interpreted as a weakness in future CSG applications). + There is “very heavy subsidization of the Clinical Trials Office,” where HCI spends $12.2 million for the 511 patients who participate in research — (nearly $24,000 per research Participant). In Pediatrics, the most active clinical trials program in the health sciences, the clinical trial office costs average $2,400 per subject enrolled ‘senvanay feu) HOM Be spun coeq 0,098 TA one OHO HOH NO TASS Sarno Sw Ses TST CBO Partners HCI Sources and Uses of Funds Productivity and Efficiency of the HCI Research Enterprise August 29, 2016 UUHSC contracted with CBO Partners for an objective analysis of the costs and supporting sources of revenue needed to recruit and sustain faculty to occupy research space currently under construction. The first phase of the project is to identify the sources and uses of funds for the current Huntsman research enterpy and an assess the productivity and efficiency of the research activity, including recruiting costs, faculty salary levels, space, extramural funding, administrative costs and efficacy of research cores Succeeding sections detail our findings and conclusions. Key points: > 7 Major sources of revenue are grants and contracts, transfers from the Huntsman Cancer Hospital, and state support, accounting for over three-quarters of all revenue in EY 15. Grants and contracts revenue grew by an impressive 14 percent from FY 14 to FYIS, Personnel costs account for 64 percent of expenses. Staff account for three times as ‘ouch of the salary and wage expense as faculty. HCI has enjoyed positive margins for at least eight years, creating reserves totaling $44.1 million. Recruiting costs for junior faculty appear high compared with other academic medical centers. However, the FYS total startup spending by ICI appears low in light of the outstanding commitments to recent recruits. Facilities and administration support is a relatively low 32 percent of HCI grants." Principal investigators in HICI space brought in an average of $384.6 thousand in total grant funding in FY15. Some faculty were very well funded, but 26 percent had no extramural funding Faculty in HCI space covered 24 percent of their salary on grants in FY1S. Space productivity was reported to be impressive $631.6 total research dollars per square foot in FY12, the latest year for which data were provided. But this number appears to include clinical trials revenue. And only 16 percent of the building space is counted as, research space in this calculation. "This is based on total facilities und administration (“indirect”) recavered, including the portion not returned to Hcl CBO Partners > We were able to check faculty salary levels against AAMC data for 47 faculty who received some salary support through HCT managed grants or other HCI revenues. ‘The majority ~ 27, or 63 percent — were above the median salary for their rank, department and degree. > Users, through charge back user fees or direct use of research grant dollars, pay a relatively small 36 percent of the costs to operate core facilities. Core income exceeded expense in FYIS, but core expenses exceeded revenues for the three years ending FY15. v August 29, 2016 ‘The Clinical Trials Office has a large budget relative to the number of patients enrolled in trials, Expenses exceeded extramural direct revenues by $5.4 million in FYS. HCI Sources and Uses of Funds HCI revenues have exceeded expenses in each of the last four years, producing margins ranging from $2.4 million to $10.3 million. HCI REVENUES AND EXPENSES S MILLIONS FY12 FY13| Fyi4/ FY15 Revenues 53.7 54.2 62.8 59.1 Expenses 49.5 51.8 52.4 55.8 Margin 42 2.4 10.3 3.3 At the end of FY 12, HCI reported $28.1 million in unrestricted cash on hand, Based on the ‘margins generated in the next three years, HCI had $44.1 million cash on hand at the end of FYLS, or enough to cover over 9 months of expenses at the FY15 spending rate. 2| CBO Partners ‘August 29, 2016 Sources ‘The two major sources of revenue are grants and contracts (43%) and transfers from the Huntsman Cancer Hospital (22%)? These two sources accounted for 65 percent of HCL revenues in PYIS. The 14 percent growth in grants and contracts from FY14 to FY1S is particularly impressive in this highly competitive research funding climate. HCI REVENUE SOURCES $ MILLIONS FYI3 | Fvis| FYIS TICE gifts unrestricted so] 32] 33 HCE gifts restricted 44} 9] 22 HCH MOU 75) 165] 130 Grants & Contracts 188} 200] 228 Grant Returned Overhead 25] 25] 25 Tobaceo/Cigarett gift 40] 40] 40 ifts/Endowments us] 19} 12 State Appropriation 1s] 42] 18 Other 64] 71) 71 O&M 14] 14] TOTAL REVENUE 542| 62.8] 59.1 Three revenue sources are from the State: tobacco/cigarette gift state appropriation, and ‘operations and maintenance support. Together these three sources accounted for $7.2 million, or 12 percent, of FY1S revenues. Gifts — unrestricted, restricted, and in the gifts/endowment category — account for $6.7 million, or 11 percent, of FY1S revenues. The bulk of the other revenue line is generated by core facilities, and in tum used to defray expenses of operating them. Uses Expenses can be sorted by natural classification (salary, benefits, supplies, ete.) and by program (rescarch administration, clinical trials, etc.) Starting with the natural classification, the major expense is personnel, accounting for 64 percent of total spending in FY LS. HCI receives 35 percent of the indirects earned on grants through the cancer coner, reported in the grant returned overhead line. tn tum, they share 7.5 percent ofthe foal indirects with the department where the faculty bave their Primary appointment. 3|Page CBO Parmners August 29, 2016 Faculty accounted for $6.4 million of total salaries in FY15, with salaried staff, hourly staff, trainees and other accounting tor the remaining $20.1 million of salaries. Thus, faculty accounted for only 24 percent of total salary in FY1S. While HCI covers a portion of salaries as, part of some startup packages. Departments, rather than HCT, are generally responsible for ongoing coverage of faculty salaries. This explains. atleast in part, the disproportionate spending on staff relative to faculty salaries. HCI EXPENSES NATURAL CLASSIFICATION, S MILLIONS: ryi3 | Fyis | Fvis Faculty 58] 60[ 64 Salary Staff 143] 146] 160 Hourty stat 33) 33| 33 Trainee o7| 07] 06 Other OL 03 ‘Total Salaries and Wages 243| 246] 265 Benefits gl) 88] 94 ‘Total Personnel Expense 324) 334] 35.9 Consaltants or} or] o1 Equipment 33} to] o8 Insurance ot] a1 Repairs & Maintenance 20) 19] 24 Scholarships/Fetlowships 05} o4] 03 ‘Space Rental oz] 02] 02 ‘Subcontracts 09) 07] 13 Supplies 48| 49) 51 Travel os| os| 06 UH Facilities & Engineering Calversity Services 13) 17] 22 Other st] a] 73 ‘Total Non-Persounel Expense 194| 190] 199 TOTAL EXPENSE sis| sz4| 55.8 cage costs included in FY LS expenses. HCI identities I of startup pa 7 We would ave expected this number tobe higher ackages for FY'15 and FY16 fo ihe 14 recnitats ols Ctl 1 eon oc ee = would tke sane six vente spent the tatu fads es CBO Partners August 29, 2016 ‘There are some 390 salaried staff in HCI, with an FY15 cost excluding benefits of $16.0 million, The single largest group is in clinical trials — 106 staff, and $4.4 million salary expense. Key administrative functions — general administration, computing and technology group, public affairs/communications and facilities — account for 32 staff, and $1.7 million. Shared resources engage another 25 salaried staff, with $1.2 million in FYIS salary expense." Departments are generally responsible for recurring salary and benefit support for principal investigators. Even so, HCI’s personnel expense for FY15 of $35.9 million exceeded the total direct grant and contract funding of $22.8 million by $13.1 million, or $7 percent. * We were unable to allocate 37 postions ($1.0 million) that had organization codes not onthe ist of ICI ‘organization codes we were furnished, and did rot allocate an additional 35 post dac positions included in salaried staff expense ($818.5 thousand). Staff and salary expenses for cemaining functions: research informatics (16 positions, $907.9 thousand); high risk cuncer research (18 positions, $881.3 thousand); center for quantitative ‘acer imaging (11 positions, $877.1 thousand); population science research (27 postions, $813.8 thousand); fesearch administration (18 positions, $808.4 thousand); pedigree and population science (18 positions, $760.1 thousand); labs - discovery research (22 positions, $685.6 thousand); labs ~ translational re $617.4 thousand); patient and public education (1 positions, $231.5 thousand); and multidiseiplinary disesse groups (3 positions, $156.9 thousand), 5|Page CBO Partners August 29, 2016 Looking at expenses by program, clinical and translational research is the single largest program expense, accounting for $22.6 million, or 41 percent, of $55.8 million in FY15 spending. General research, which includes research administration, research informatics, and shared resources, is the next major program area, comprising $10.1 million (18 percent), followed closely by $9.1 million (16 percent) in general and administrative expenses. These three program areas accounted for 75 percent of total ICI spending in FY IS. HCLEXPENSES BY PROGRAM '§ MILLIONS Fyi3|-Fyia]__‘FYIS Laboratores 73 78 6a Total Discovery R 73 78 64 linea Tale 88 98 122 Laboratories 52 53 6a Molecular maging Program 52 Cri for Quant Cancer Img 29 29 Muliiscipinary Programs 06 03 03 over 06 os 07 Total Clinical / Translational 20.4 22.6 Research Information 16 3.0 Research Administration 28 19 ‘Shared Resources 49 50 Over os 02 Total General Research 38 108 40.1 High Risk Cancer Research | 20 18 18 Pation & Pubic Education o4 oa oa Pedigree & Population Si 19 1a 18 Population Science Research oa 03 29 Prevention & Outreach 2a 12 Total Prevention / Outreach 65 54. 69 computing & Tech Group | 12 LL 13 Development Facies 23 49 General Administration Ba 3a Pubic Afar communications 12 Total General / Administrative 78 Total Expenses 518 524 6|Page CBO Partners August 29, 2016 Productivity: Faculty and Space Faculty ‘The Cancer Center includes 186 members of which 179 were included in the CCSG renewal’. HCT had $62.7 million in total cancer funding, and $47.6 million in direct funding. The average HCC investigator funding level is $255.8 thousand in direct dollars, and $337.3 in total dollars. ‘The 80 investigators located in HCI space® have $23.4 million in direct funding, $30.8 million total funding, for an average of $384.6 thousand in total funding per investigator located in HCL space. The 106 Cancer Center investigators located outside of the HCI have $32.0 million dollars in total funding, for an average of $301.5 thousand in total funds. A significant percent of the HCI funding base is made up of industry awards. As a result, the percent of F&A returned on HCI awards is relatively low, at 24% for grants in both HCI and external space, Hl investigator Funding by Location of Investigator Direct Funds Total | Percent F&A Located in HCL 523,388,667 $30,771,429 24% Externally Located $24,198,704 $31,957,888 28% ‘AIL HCl Investigators $47,587,371 $62,729,317 24% Extramural Funding of HCl investigators by Location of Laboratory Located in HCI__| Externally Located | All HCI Investigators Direct Funds $292,358 $228,290 $255,846 Total Funds | $384,643 $301,490 $337,254 Avera The average research funding for HCI investigators is weighed down by the large number of the investigators in HCI space who do not have research funding (21 of 80, or 26 percent). An even larger proportion of HCI investigators located in extemal space have no extramural funding - 46 percent. Of the 179 investigators included in the last competitive CCSG renewal, 70 FIC investigators did not have extemal cancer funding. Of the 70 CC investigators without research funding, 21 are located in HCI space with 49 in external space. * Data in this section is drawn from Data Table Two (2015 data) in HCI’s submission to NCI. UUHSC provided salary data on 161 cancer center investigators, of whom 154 are included inthe CCSG. The diffrence may be due 1025 investigators aot in ffealtn Science departments, © Salary data for faculty in HCI space identified 72 faculty, 8 fewer than in Oata Table Two. 7|Page CBO Partners August 29, 2016 ‘Summary of HCl Investigators Without Funding by Location [Located in HCl Externally located ‘Number of HCI Investigators 30, 106 # without funding 21 43 ‘% without funding 26% 46% HCl achieved highly impressive scores from the 2014 site visit. The trajectory in site visit scores from 2003 to 2009 to 2014 is terrific. The award of the Comprehensive Cancer Center designation is testimony to this progress. That said, having so many CCSG investigators without extemal funding could be a problem in future reviews, As detailed in the table below, many of the HCI investigators are very well funded, with 32 of the investigators having more than the equivalent of two NIH R awards. We treated major awards from foundations (e.g, American Cancer Society, Leukemia and Lymphoma Society) and the Department of Defense as an R equivalent award. Overall, the funding levels of the investigators with support are quite impressive. The challenge to HCI is to inerease the percentage of members who are funded. An impressive number of training grants were reported in Data Table 2. However, the principal investigators of the training awards do not appear to be major cancer investigators, based upon the fact that only three of the thirteen investigators had other cancer funding. Summary of Grants by HC! Investigators Funding Summary Number of investigators ‘Three or More "R” Equivalent Awards i Two R Equivalent Awards 21 (One R Equivalent Award 40 P.l.on Sub Award > $50k i P.1.On Sub Award < $50k 8 T32/other T (10 of Ps only have the Taward) 2B Industry funding > $100k 19 Industry funding< $100 6 Salary coverage on grants is low. For faculty housed in HICI space, 23 percent of salary was covered on grants in FY1S. For all cancer center faculty, 22 percent was covered. CBO Partners August 29, 2016 Space HCI phase one contains 231,118 square feet. of which 44,547 to 47,299 is wet lab space’. To calculate research dollars per net square foot, HCI adds indisects to its grants and contracts directs total, and subtracts 7,144 square feet identified as bubble, TRAC. MicroAmray and vacant from the 44.547 to get uet lab square footage of 37,403." It appears that clinical trials revenue are included in the numerator. Research space productivity calculations should exclude clinical trials revenues to get an accurate assessment of productivity of basic research space. In addition to the issue of including clinical trials revenue, only 16 percent of the building space is counted. The total research dollars per net square foot reported by HT are: RESEARCH SPACE PRODUCTIVITY ' PER SQUARE FOOT Fyoo | rvio [ ry [ rye 3775 | 4497 | 5934 | e315 Using this methodology. dollars per net square foot grew at an 18 percent compound annual growth rate Start Up Packages Startup costs are shared between HCI and the recruit’s home department. Fourteen faculty were recruited with start dates in FY15 or FY16, at a total startup cost of MM HCT's share of this is IIE or just under bal Six of the recruits are professors, four non-clinical and two clinical. Average recruiting costs were [IIB] for the non-clinical and II for the clinical Cue fhe rian potescr vines one > TTT The recruiting cost o may not represent atypical package. parteularly mt light of the fact that i is less than the averaze for assistant professors recruited m the sanue time fraune Seven of the recruits are assistant professors. three nou-clinical and four clinical, Average recruiting costs were for both categories Recruiting packages for seaior faculty are highly variable, depending on particular institutional reeds and candidate talents, track record and competitiveness ‘Two different numbers appear in material provided to CBO Partuers, "CHO Pariners asked for a more detailed explanation ofthe 7.L.L4 square feet subtracted is this ealeulation. None was received a} CBO Partners August 29, 2016 At the junior faculty level, cecruiting costs tend to vary less across institutions. These recruiting costs for assistant professors appear high compared to other academic medical centers, Faculty Salary Levels ‘The AAMC Collects data on tenure track faculty salaries by rank, department, and degree. Eighty-seven faculty received some salary support from HCI in FY 15, mostly from grant revenue but also from other HCI sources. Forty three of these were tenure track and had a department that aligned with the AAMC departmental categories. Seven of these had salaries that were below the 25" percentile for their rank, department, and degree. Nine were between the 25" percentile and median salary. The remaining 27, or 63 percent, were above the median salary for their rank, department, and degree. This may be explained, in part, by compensation for administrative duties undertaken by some of these faculty Efficacy of Research Cores Shared resources are a very important component of successfull cancer centers. They provide valuable resources in a more cost effective fashion, reducing duplication of services in laboratories. In the most recent competitive renewal, the included shared resources received very positive reviews. New shared cores, and important but not widely used cores, often initially receive significant institutional and cancer center support. As cores mature, more of the core expenses should be paid through user fees User fees make up over half of revenue in only one of the six cores included in the CCSG renewal, the High Throughput Genomics core.” The core support model includes support that comes from research grants and this makes up 36 to 37 percent of the budgets for the Utah Population Data Base, Genetic Counseling, and Cancer Biostatistics. Overall, given that these cores have been functioning for several years, the users, through charge back user fees or direct use of research grant dollars pay a relatively small percent of the budgets to operate the cores. It is common practice for some cores (biostatistics, bioinformatics) to not directly charge user fees. However, CCSG reviewers expect to see a larger percent of the budgets being supported by peer reviewed grant dollars. HCI should develop a funding model that will over time rely on the core users to support a larger percent of the core budgets. Providing inexpensive access to high quality cores can be an important tool for motivating cancer research; however, free or very inexpensive services can be abused. © ffom the 2015 CSG competitive renewal " Dats in these paragraphs and the following table 10|Page CBO Partners August 29, 2016 Investigators should be paying a larger percent ofthe operating budgets of the cores, either through user fees to dollars from their research grants, ‘Shared Resource Budget Support {This data is from the last CCSG Competitive Renewal) Sources | UPDB | Genetic | High Research | Biorepository | _ Cancer of Counseling | throughput | Infrastructure | Molecular | Biostatistics Support Genomics Pathology ccs o% o% oe Ga oe % User fees | 10% 0% 71% om | 3am % HCI 23% 58% 3% Bax —| 88% 35% Institution | 24% | Tom, Biostatistics | 377,060 | 17.018 | ix | on | ox | ox] ix] om [a2 [ox Fg 7038566 | 218,607 | is% | ax [ise |—ox | osm | om | 2% | om throughput sznomics Molecular | 3255] 7519 | tex ux | — Date: Sunday, December 4, 2016 at 9:20 PM To: Wyatt Hume , Patricia G Morton , "Kristen A. Keefe" , "Peterson, Randall 7,Ph.D." , David H Perrin , Gordon Crabtree , Mary Beckerle , "Braendle, Edgar" , Jean Shipman , Cynthia Best Ce: David Browdy Subject: Bonuses and Comp changes Dear team, Dave Pershing and | discussed last week the critical need to ensure that are incorporating best practices with regard to salaries, bonuses, and significant changes in pay, as we want to make sure that we are excellent stewards of the money entrusted to us, In line with this, we remind you that before you take action on bonuses, salary supplements, and/or significant changes in pay for individuals in your areas, you should get SVP's office approval. If you are considering this sort of action, please submit your proposals to David Browdy and me. ‘Thanks so much, Vivian From: aid W. Pershing To: ‘wan Lee Subject: Re: checking a Date: Monday, December 05, 2016 7:51:53 Hi Vivian, | spent almost 2 hours with Peter and we did make a lot of progress, at least as far as understanding how each of us see the HC! world from very different perspectives | am sure this will take much of our hour together on Wednesday but | am hopeful that together we can make some very real progress that could make the future much more collaborative. Dave Monday, December 5, 2016 at 5:29 PM To: David Pershing Subject: checking in Without going into a lot of details necessarily, did it go ok today? ‘Thanks. Sunday, December 18, 2016 10:15:06 PM OH, ‘Still, none ofthe money goes to the Huntsman Cancer Foundation so 1 don’t see why that is her issue. (On 12/18/16, 10:13 PM, "Vivian Lee” wrote: >The trouble is that she usually questions whether we are honoring the MOU >with the margin calculations etc. So she doesn’t just chink she's fund-raising. >On 12/18/16, 10:12 PM, "David W. Pershing” wrote: >My thinking exactly. am thinking of saying that we were not planning > to talk ebout fund raising at al, - whi >tomorrow is > on honoring the MOU, clinical topies and research. How does that is true. The focus > on 1271816, 110 PM, "Vivian Lee >oh thas not ely parity good news > St wonder iyou can ask fora private meetin with him, Ori an 2 Satin. rife sold ve Pal jon im. rj about any ter > Sopion > Sein not sre what open > Stoo bad we cou jst go otto Heuston, 5 on 1/116, 1005 PM, Davi W.Penting® Soot > Vivian, > What do you make ofthis? Not good I fear. [wish itwas >David > > Huntsman > > On 12/18/16, 9:58 PM, "Peter R Huntsman’ wrote: > Dear President, > >lust an FYI shall be accompanied by Susan Sheehan (assuming 5 vv vvvvvvvy brourmesingomorow >itismy understanding hat you wil have Vivon Le. Looking forward to sein you > Rega? Sper From: David. Beshing Te: ion Lee Subject: Re: Date: ‘Sunday, December 18,2016 10:12:03 M My thinking exactly. am thinking of saying that we were not planning (o tak about fund raising at all,- which is true. ‘The focus tomorrow is ‘on honoring the MOU, clinical topics and research. How does that sound? Dave (On 12/18/16, 10:10 PM, "Vivian Lee" wrote: >Oh that's not really particularly good news, 1 wonder if you can ask for a private meeting with him. Or iff can meet >with him. Or if he could have Paul join him. Or just about any other >Doption, Else I'm not sure what to present. >'Too bad we couldn't just go out to Houston, >On 12/18/16, 10:05 PM, "David W. Pershing" >wrote ‘What do you make ofthis? Not good I fear. I wish it wus David Huntsman inthis role. Dave (On 12/18/16, 9:58 PM, "Peter R Huntsman" wrote: > ear Presiden, > an FY, stl be companied by Susan Shean suming eis cr eg tro >itismy understanding that you wl ve Vivian Le Looking fra eng SRepaie rete vv VVVV VV VV VV VY VV YY From: Did W. esting To: eter Huntsman ‘Subject: Re: Date: ‘Sunday, December 18,2016 10:22:28 PH Dear Peter, ‘Thanks forthe heads up on that. I do hope that Susan has recovered, ‘but {am not sure she is an appropriate person for the meting tomorrow. ‘Our plan was to focus on the 2014 MOU, the generation of new funds by the HCH and mostly on cancer research and clinial eare, To be sure it would be appropriate to have a fund raising discussion with Susan,perhaps in our next meeting, but I didn't see that as our most bumming issu. See you in the morning about 9:00 am, Best, Dave (On 12/18/16, 9:58 PM, "Peter R Huntsman” wrote Spear Present, Sst an FYI shal be companied by Sisan Shean (suming shi oreurmecing omorow. >itismy understanding tat you wl have Vivian Lee ooking foward to seing you. >Repars? ester From: idan Lee To: Davi, Pershing Subject: Re: Date: Monday, Decenber 19, 2016 7:13:39 AM ‘The unspoken issue isthe confident trusted Peter with this, ity of what we were going o share, Our candid assessment, I would have ‘Susan has the ability (and likelihood) of bringing it to Jon and to Mary, in whatever way suits her own interests, “That's really the key issue here, Do we feel comfortable having this g0 to Jon? (On 12/19/16, 7:04 AM, "David W. Pershing" wrote Good moming Vivian, Just so you know Susan is coming. We will just have to do the best we can, See you in a couple hours. Dave (On 12/19/16, 5:19 AM, "Peter R Huntsman” wrote: Thank you President for your response. [ hink for purely reasons of >etiquet, [ will bring Susan given the felings it may stirifT were to >'disiavte’ her. Lsee your point, My father had asked that I have someone accompany me who >had some experience predating my time. As I didnt want to get lawyers involved, or additional family members, Susan seemed to be a good choice. Should the discussion not cover her arcas of expertise or knowledge, >will >keep her participation to a minimum. > Many thanks. >Peter >> On Dee 18, 2016, at 10:23 PM, David W. Pershing >> wrote >> Dear Pete, >> Thanks forthe heads up on that. { do hope that Susan has >>recovered, >> but [am not sure she is an appropriate person for the meeting tomorrow. >> Our plan was to focus on the 2014 MOU, the generation of new funds by >the >> HCH and mostly on cancer research and clinical care, To be sure i 8 would 2 trope to havea id wextmeeting, but id see hat sour most buming ise > see you nthe mming haut 9:00am, Best, Dave > on 2186, 9:58 PM, -PoterR Hunan wrt > Dear President, 35> Just anPYL sal be acompaid fy Susan hochan assuming sh i 2 rar mening tomomon 2S viamy understanding tat you whe Vivian Lee 2 Looking forward secing you 23> Repads? >> Peer discussion with Susan,perhaps in 8 From: David. Pershing To: ivan Lee Subject Re: bonds Date: “Tuesday, December 20,2016 9:37:19 PM Hi Vivian, This is important to understand. From the message below, | gather that the Huntsman side is responsible for the payments on the Phase IV building but we must cover the bonds that remain on all the other buildings. Have | got that correct? Yes, | am looking forward to talking with you tomorrow about all of this. | am cautiously optimistic that we might be able to use this as a turning point to get this relationship on a much better footing, Dave From: Vivian Lee Date: Tuesday, December 20, 2016 at 7:50 PM To: David Pershing Subject: FW: bonds Given the issues Peter raised of us needing to take over responsibility for bonds, this is the information I got from Gordon about the bonds. I don’t think his version of history is accurate —Jon is not on the hook for any bonds other than the Phase [V project. Let me know if there are any other questions | should be exploring or researching further in light of that conversation. ‘Thanks a lot and see you tomorrow! Best, Viek From: GORDON CRABTREE Date: Tuesday, December 20, 2016 at 11:07 AM To: Vivian Lee , DAVID BROWDY Subject: RE: bonds | have done the research and have the following responses from the “experts”, First, in regards to the debt service obligation for the bond payments---our Bond Counsel states the following (emphasis added): Gordon ~as we discussed, there are a number of bonds outstanding for the Huntsman focilties. Some were issued by the State Building Ownership Authority with a lease to the State and a sublease to the University, some by the Board of Regents on behalf of the University and most recently Salt Lake County issued a conduit bond for Huntsman's. Leaving aside the Bond issued by the Countyfor Huntsmons, the other bonds are payable from University revenues (through lease payments or a pledge of revenues). In each case, the facilities are to be insured so that they would be rebuilt if destroyed. (Blake Wade of Ballard Spahr LLC) Concluding note: Bondholders will only look to University revenues for debt service payments--- in the event of HCH burning down Second, memo only: related to insurance coverage to rebuild HCH after the fire: The first $1,000 of property lass to any U building or contents is born by the university. The Utah State Division of Risk Management provides the next $4million of coverage and purchases commercial excess property coverage beyond that. (Jerry Allred—UofU Risk Manager) Hopefully, this gives you what you need. Thanks. From: Vivian Lee Sent: Monday, December 19, 2016 9:28 PM To: Gordon Crabtree ; David Browdy Subject: bonds (One question that Peter raised was what happens if the HCH were to burn down? Are those revenue bonds for the $100M (+34M interest) that are still outstanding? Is it true that HCF or Jon H is named on those or is it the University? I don’t know. He was confused and certainly is going to try to figure it out. I'd like us to figure this out too. Who can tell us? ‘Thanks! Te Vian Lee Subject: Re: Dra message to Peter Date: Wesnestay, December 21, 2016 10:29:18 8 Excellent. Major improvements. Iwill send itoff, Best, Dave From: Vivian Lee Date: Wednesday, December 21, 2016 at 9:20 PM To: David Pershing Subject: Re: Draft message to Peter ‘Thanks Dave! I made a couple minor edits. See what you think, Thanks a lot. I hope he’s straightening out the story with Dad. From: David Pershing < > Date: Wednesday, December 21, 2016 at 4:40 PM To: Vivian Lee Subject: Draft message to Peter Dear Vivian, ‘Thanks for a great meeting today. 1 felt like we accomplished a lot and I certainly learned much, Here is my rough draft of a message that | might send to Peter. See what you think, Dave Dear Peter, First, a huge thanks to you for taking two hours to meet with us on Monday. We felt like that was very helpful because we need to understand much more about how your family sees these big issues. Second, | hope that you are indeed getting a few days completely off the grid and this message is certainly not meant to interfere with that. You clearly deserve it ‘Third, Vivian and I are very excited about the possibility that we can pivot this relationship by quickly tying up the loose ends from the past and begin focusing on the huge opportunities we see in both cancer research, including genetics, and cli wre of cancer patients going forward. Strengthening the national reputation of the Huntsman Cancer Institute as a destination cancer care center and as a renowned center of discoveries and high impact science is our common goal. We feel like we are poised to make huge steps forward on both fronts, but we must be real partners for this to be successful. After you have had a chance to digest our charts and think about your internal views, we would be glad to come to Houston to meet so we can keep the momentum going forward. Merry Christmas and best wishes for a great holiday. Dave From: wan Lee To: ster Huntsman Subject: nvtaton Date: “Thurstiay, January 26, 2017 3:49:33 PM Dear Peter, | hope you had a good holiday break and that the new year is offto a great star. Pres Pershing raised this with you inthe fall, and {hope you will consider it favorably—we would love to invite you to join our University of Utah Hospitals and Clinies board starting this summer/fall. This has been a wonderful year forthe hospitls and clinies—we’ve been recognized for being top in quality in the nation among unive hospitals, for bringing disruptive innovations to market, for lowering costs, for leading the nation in patient satisfaction, As you know the Huntsman Cancer Hospital is part of our hospitals that are the purview of this board, ‘and we think that you would be an incredibly valuable member of the board, given your incisive business acumen, prior service on another hospital board, and connections here. ‘Would you be willing to take a call so I can talk a bit more about what the board postion involves? I can work around your schedule. ‘Thanks so much, Best, Vivian Miva Lee ese tuntsman UU Hospital Board - general responsible / tne commnisrent “Thursday, February 16, 207 9:21:20 PM ‘Thanks for taking the time to talk about serving on the U's Hospital Board ‘You asked for some more information about serving on the Board. Below is. lst of general responsibilities and scope of authority, time commitment, and current dates for 2017-2018 mgs. We'd be thinking about starting this {ll i that works for you and welcome you to join carlir mi you'd like t0 observe. We think you'd be absolutely amazing and would just be thrilled if you would join our board. And yes, call-ins are completely fine. We'd just send you the link to the slides. [ve attached a pdf of our new Value booklet that highlights afew ofthe quick facts about our health care system, Ifyou have any questions please let me know. ['m also available any time to meet when you come to town, "hanks so much Peter, Vivian UU Hospital Board: General ResponsbilitiesScope of Authority Evaluate and approve policies consistent with the mission; Review Hospital budge, land purchase considerations and financial reports before they are sent to UU Board of ‘Trustees for approval; ‘ofthe Senior Vice President for Health Sciences, inthe selection ofthe Chief Fxecutive Participate, atthe divest Officer of the Hospitals: Review and approve the Medical Staff Bylaws at regular intervals; Act on recommendations from the Medical Board regarding medical sta appointments (a physician's privilege 10 practice at UU healthcare facilities); Final step of review in actions to revoke a physician's medical staff privileges (extremely rare); Provide oversight forthe Hospital's ongoing Quality Program focused on service quality, appropriateness of patient care, clinical and business processes; ig the scope, programs and se Periodically review and give input regarding strategic long-range plans outl sto be provided by the Hospitals; Evaluate and approve annual program priorities, including quality, operating and capital budgets; ‘Monitor and evaluate operations, programs, fcilites, strategic plans and capital expenditures to assure that they are consistent with the Hospital's mission, long-range financial stability, services and educational needs; Advocate forthe Hospitals and their programs, services, performance and plans to community constituencies; Assure the Hospitals are committed to and responsive to meeting community need, and is promoting wellness to the ‘community. UU Hospital Board: General Time Commitment: 9 meetings! year (usually held last Thursday ofthe month. No meeting in December, July, or August) 1 retreat —usually held in October (usually noon on a Friday until noon on @ Saturday, Deer ‘Valley/Stein Erikson) 1 committee assignment — typically held immediately before or ater a board meeting “Board Connect” — board rounding —6 times a year vi ask a specific question about quality / service patients on an assigned Hospital unit to Optional — participate in recognition rounding for high performing units (perhaps once a year) (Currently scheduled Board mig dates 1 Apwit 27,2017 2 May 25,2017 3. June 22,2017 4. September 28,2017 5. November 16, 2017 6. January 25,2018 7. February 22,2018 8 March22, 2018, Apri 26, 2018 10, May 24, 2018 11 June 28, 2018 12, September 27, 2018 13. November 15,2018, cree H gE ie aero) SEE) \@)fe] TAXON IN eve) H11W3H 4O 3aNind ‘AHL YOd NOISIA Y 0 sowy suo10%9 9 moan ey 502 VoNonOE WON EAI 4809 183MO1 3HL Lv HITV3H 1839 3H SVH H¥LA ays. “yun 19 10 406 p01 ‘wou 0 bajo voqotou pu 6avon Np 263 oxh oho 20 aoa yan fo Aaa) “eos ans en wens os amy eo wemos oxo 9 Boney SOD GIN MOU 21uNID okay ‘039 18UL104 GW ‘2801109 “y sluag ~ “WOUN}OS YO4N ey) JNoqD 6ury}p) 404s PUD fountos Youers out JOU eys jnogn Buryjo} doys of oui H11W3H 3NTWA-HOIH NI NOILYN 3H1 ONIGW3T Jooyas ssoulsng pusioH ‘aud “uojdoy "s 408qey 0102 41094 njoned ves 4) voutomuodio eu #5141, =. helped oe NOUNNOS SIVA HATY3H W¥An 30 AUSIBAINN NOILVNO3 3NTVA-HOIH V NO ONINSAIIIG oyeouruc 9 uns e469 wounues ae m0 sg raul nmi oO ioe__o1e_g002__s00% ‘hupunvorts eu oq rr uosranne noe roa, fore UO ou Jae ood {srs dy 20 0 0 ponders wor yoo Hep yo sony ware at ea mca _soe-e00 Guan nou uronsa wmooy Among eines ‘9102 ‘01 1990120 ‘soni jov9seq .'uoyue}j0 Budod oo SI pom ayi-wepehs 210 YI 6. Md. PsEOG OURS SHON T01080q — ost 7S’ 244 Ut s}oyidsoy >1LWepo20 sa yo Buown Bupjuns | ‘ON 24) 04 S010) 0409 Yypooy £9 ‘24f Pde] Padjey soy pud e>d}0U joUODULE|U! BuYy20140 ew Jo Alenljep PUD s{s0> ay} Bulssasso >AOUU] PADMO} Ysnd Buo|-iDek-inoy y “uoUEL.D wont} ie So BurAod s1 pjsom ayy pup — pliom oy} jnoyBnosy) Ing ‘e194 ihe) & s Ajo Jou posenljop pu pesiid s} e1D> jooIpeul ADM ayy pO ee Oa a ee 9Z1UO\NNJoAed 04 Buls}woud s,jo4} Wa}sks e105 YsJOBH YOIN Jo man =O syoudscy peyonuye 104! ye #24 YOY! JOU pu ste(ue2 jo2jpeU! 29w9pO20 QO} Jo MD {TVD HLTVAH HVLN JO ALISUBAINN YOd ONIN ALITVND TYHOLN ALIMWA® NI NOLLVN 3HL ONIGVaT Aijsseqiun 24) 4D uo BuloB Aiouipiop1yxe Bulyjoluos 5.2124, ‘ew 0K MON i Aa wo #8371 OP OF ALIS #101209. ‘DH0I0y OUI ~ | atyuacied yj66 844 Ul 240 yud2I0d 9z pud ejyuacied 406 eYf Ul e1D Ss@pinosd sy JOY ‘MON, ‘hanans kouDd ss81q 84} UO AIJOUOYOU 2]4UADI8d YIOE 24h snogo ul spm 4! ‘uDB9q [YoIN Jo] AisiienlUN ay) UayM “JOB JD21pew p owW039q soY-y195)! 2103 [poIpaw Aq ing asDasip Aq jou pesno> pury e4)—Bulieyns juoyod Bursnpos~ Smoe MONE eee NOILOVASILVS LNAlLVd NI NOILWN 3HL ONIGV31 SLNAWWO9 GNY SONLLYE 3NITNO 3L1S83M 300 V GNIS oz 't eunf manay ssousng pionioy, 2umnipaus xy day pyn03 sme; UNO, “any ‘e073 oun 10} 49449q aq |!M 9109 jueyDd pud PEO! siys UMOp 06 | |S4Y 24} SOM YoIN JO AUISJ9AIUN OMA, AONIAVdSNVAL NI NOILVN 3HL ONIGV3T iow > 009 280 ny yon 10 Ayss20up AN3W32¥1d38 LNIOI TWLOL 404 38V9 40 1809 IOWUIAY oe 2s0907%0 9M Ms. Irray 2109 HOEK © BuNeD RaW. MED ~ [2109 30 Auyjonb oyj Buluiwopun jnoyyim 1! s10u)u9 oF moy 40 'S! 218" 84) 818yM ‘S103 8y! BUIAIP 51 ;DYM jnogo BuIyjAUD, nok |} op BIDP Yans ing “Bulpueds ou Koy) yous MOY Jo BPI {yBno1 © wus eni6 you 4509 ju2Hod-10d aB0s0R0 2]0In>q09 sjoNdsoy J50Wy ‘siUayDd 0} 102 Jenljap 0} 4809 Ajonso0 4) yanur moy mou 240 04 104) som—spIMUoHDU s]ousOY JO PUD—YOIN U! We}qoud OY, LNAWJOVNVW LSOD NI NOILWN 3H1 ONIGV31 (vay pug agg a ea 209 weap Aco —— oseug 21 aeg ———_zaseyg vey naueg jag supeseg 1 eseyg 209 904 ——paseyg aig naag axogng omeseg sary 59 seg ico eavoneecnimrssog ej unenuea, nee fo ae Eggs wot §ANaW3D¥14I8 MOI 1¥LOL MI SAWODLNO N3AING-3NTVA FaN]DA UO Pasnroj eu0 1Dy} PlioM ayy Puno swejshs 9109 YyJDoy JoYJo puD a1D> YyJDoy “S'f) Jo Jse4 OYy 404 Ing Wa!sAs e1DD YYJDEH YIN Jo Ajisseniun yy 404 ysnf you ‘papasoy days yuDjsoduu! pud ‘aatsseiduit ub si senB091/02 pup 209 hq APnjs [Jue294 y] NMOG O9 S1iso> dn $4309 ALIIVND N3HM ‘AGNLS 3SVD

You might also like